CTOs on the Move

Volpara Health

www.volpara.com

 
Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.volpara.com
  • 19000 33rd Avenue W Suite 130
    Lynnwood, WA USA 98036
  • Phone: 800.305.3865

Executives

Name Title Contact Details

Similar Companies

Ltc Providers

Ltc Providers is a Sullivan, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbria

At Symbria, we unite passion, insight, and performance to help senior-living and post-acute providers build sustainable success. We don`t make this commitment lightly, understanding full well how challenging this goal is to achieve in today`s demanding, highly competitive environment. Every service we provide – from therapy to pharmacy to wellness to benchmarking – is thoughtfully developed and conscientiously implemented to amplify your ability to effectively and cost-efficiently meet the needs of the residents and patients your community serves.

CHSTherapy

CHS Therapy and Rehab helps post-acute rehab centers create impactful care programs that lead to exceptional patient outcomes.

Peoples Health

Peoples Health is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Avexis Inc

AveXis is a clinic-ready, synthetic biology platform company. AveXis has, at its core, a desire to establish unique industry and research alliances which will bring innovative treatments to people with unmet medical needs. Our work in spinal muscular atrophy (SMA), a rare/orphan disease, is our first focus.